Lesinski, Gregory B <br/><br/>
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.  [electronic resource] 

 -  The Journal of clinical investigation  Jul 2003 
 - 170-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI16603  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Division<br/>Cell Line<br/>DNA-Binding Proteins--genetics<br/>Dose-Response Relationship, Drug<br/>Flow Cytometry<br/>Gene Expression Regulation<br/>Gene Transfer Techniques<br/>Immunoblotting<br/>Immunohistochemistry<br/>Interferon-alpha--pharmacology<br/>Killer Cells, Natural<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, SCID<br/>Mice, Transgenic<br/>Retroviridae--genetics<br/>STAT1 Transcription Factor<br/>Signal Transduction<br/>Spleen--cytology<br/>Time Factors<br/>Trans-Activators--genetics<br/>Tumor Cells, Cultured